BIOMATRIX SPECIALTY PHARMACY ANNOUNCES ENHANCED COMMUNICATION MEASURES IN RESPONSE TO COVID-19 PANDEMIC.
Early Refill Forms, Text Alerts, and In-App Chat Capabilities Improve Communication and Speed Accessing Therapy
April 3, 2020 – Plantation, FL
BioMatrix Specialty Pharmacy announced today an additional communication channel ensuring patients maintain a high level of contact with their specialty pharmacy during the COVID-19 pandemic. As part of a comprehensive response, BioMatrix is increasing patient communication and speed accessing prescription refills using a HIPAA-compliant SMS texting and chatroom application powered by Citus Health. After opting in, patients may request an early refill, receive refill reminders, and participate in one-on-one conversations with pharmacy staff in a secure environment.
“Our desire to ensure our patients on chronic and complex therapies have as many channels as possible to connect to our team during this time of uncertainty was of critical importance to BioMatrix,” stated Meagan Sampogna, Chief Operating Officer at BioMatrix. “Working with our Citus Health partners to establish a flexible, fast, and secure way to keep lines of communication with our patients open has been a huge benefit to serving our patients rapidly while reducing operational impact for our teams.”
“During these uncertain times, it’s incredibly inspiring to work with such an outstanding specialty pharmacy. The BioMatrix team prioritized real-time patient communications from the outset of this crisis and were able to launch the Citus Health solutions in record time to ensure their patients were able to quickly learn the status of their life-saving meds and how to access early refills for allowable medications,” commented Melissa Kozak, CEO & Co-Founder, Citus Health. “Our mission is to remove all barriers to patient engagement, enabling real-time communications and automating critical workflows from any device, anywhere at any time. We’re honored to provide a platform that can assist BioMatrix in business continuity, high quality patient support, and most importantly the continued dispensing of these extremely important medications that are critical to the care of their patients.”
BioMatrix continues to monitor guidance from the World Health Organization, the CDC, FDA, the Boards of Pharmacy, and other healthcare regulatory bodies at the national, regional, state, and county levels to stay abreast of impact, guidance and trends. As an essential healthcare operation, all of our BioMatrix Specialty pharmacy locations will remain open throughout the COVID-19 pandemic. We continue to monitor product availability and courier status to ensure our patients maintain timely access to their medications. For more information on efforts BioMatrix has taken in response to the COVID-19, please visit https://www.biomatrixsprx.com.
About BioMatrix Specialty Pharmacy
BioMatrix Specialty Pharmacy offers comprehensive, nationwide specialty pharmacy services and digital health technology solutions for patients with chronic, difficult to treat conditions. Our commitment to every patient is to provide individualized pharmacy services, timely access to care, and focused education and support. We offer a tailored approach for a wide range of therapeutic categories, improving health and empowering patients to experience a higher quality of life.
About Citus Health
Citus Health is a digital health transformation leader that enables real-time, secure collaboration between patients, care teams, care partners, and family members to optimize the patient experience and positively impact the financial outcome of the care provider. Founded by a post-acute care nurse with domain expertise, and an internationally recognized med tech expert, Citus Health delivers the only comprehensive on-demand digital and mobile solution set that transforms archaic processes to set a new standard of patient care and engagement. For more information, visit https://www.citushealth.com/
Source:
https://www.biomatrixsprx.com/news/enhanced-communication-measures-in-response-to-covid-19-pandemic
No Comments